Published in Scand J Gastroenterol on November 01, 2002
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Celiac disease and autoimmune thyroid disease. Clin Med Res (2007) 1.42
In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med (2006) 1.34
Liver complications in celiac disease. Hepat Mon (2011) 1.01
An unusual cause of adult onset cerebellar ataxia with hypogonadism. Ann Indian Acad Neurol (2009) 0.86
Peripheral neurological disturbances, autonomic dysfunction, and antineuronal antibodies in adult celiac disease before and after a gluten-free diet. Dig Dis Sci (2006) 0.84
Sensorineural hearing loss and celiac disease: a coincidental finding. Can J Gastroenterol (2009) 0.80
Multineuropathy in a patient with HBV infection, polyarteritis nodosa and celiac disease. Rheumatol Int (2008) 0.79
Neurogenic chronic intestinal pseudo-obstruction: antineuronal antibody-mediated activation of autophagy via Fas. Gastroenterology (2008) 0.78
Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J Neurol Neurosurg Psychiatry (2005) 0.78
Differentiation between Celiac Disease, Nonceliac Gluten Sensitivity, and Their Overlapping with Crohn's Disease: A Case Series. Case Reports Immunol (2013) 0.78
Recurrent ischemic strokes in a young celiac woman with MTHFR gene mutation. World J Gastroenterol (2012) 0.75
Effect of a Gluten-Free Diet on Cortical Excitability in Adults with Celiac Disease. PLoS One (2015) 0.75
Clinical and immunological relevance of anti-neuronal antibodies in celiac disease with neurological manifestations. Gastroenterol Hepatol Bed Bench (2015) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med (2000) 2.40
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut (2004) 2.04
Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis (2006) 1.85
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther (2009) 1.83
Parkinson disease: the enteric nervous system spills its guts. Neurology (2011) 1.81
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. Dig Liver Dis (2005) 1.52
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 1.47
New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.45
Abdominal lymphadenopathy detected by ultrasonography in HIV-1 infection: prevalence and significance. Scand J Infect Dis (1993) 1.44
The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats. Neurogastroenterol Motil (2008) 1.44
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis (2001) 1.44
QTc and psychotropic drugs. Lancet (2000) 1.44
Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol (2005) 1.41
Bile duct cell apoptosis is a rare event in primary biliary cirrhosis. Dig Liver Dis (2001) 1.40
IgA antibodies to endomysium, gliadin, and reticulin in silent coeliac disease. Lancet (1992) 1.40
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet (1991) 1.38
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol (1994) 1.38
Thyroid function in systemic sclerosis. J Endocrinol Invest (1991) 1.38
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil (2007) 1.35
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet (1998) 1.33
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther (2004) 1.32
New insights into human enteric neuropathies. Neurogastroenterol Motil (2004) 1.31
Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet (1990) 1.30
Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28
Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther (2001) 1.24
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. Acta Diabetol (2011) 1.23
HCV and autoimmunity. Curr Pharm Des (2008) 1.22
Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A (1999) 1.22
Basement membrane production by hepatocytes in chronic liver disease. Hepatology (1985) 1.21
Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil (2008) 1.20
Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther (1999) 1.20
Mitochondrial antibodies in primary biliary cirrhosis. V. Ultrastructural localization of the antigen to the inner mitochondrial membrane using a direct peroxidase conjugate. Br J Exp Pathol (1973) 1.20
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology (2001) 1.17
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? Gastroenterology (1999) 1.16
IgA antiendomysial antibody test. A step forward in celiac disease screening. Dig Dis Sci (1991) 1.16
Evaluation of serum rosette inhibitory factors in chronic liver disease. Clin Exp Immunol (1983) 1.14
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology (1996) 1.13
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology (1993) 1.13
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
Gastric secretion and emptying of liquids in reflex esophagitis. Dig Dis Sci (1981) 1.11
Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. Clin Exp Immunol (1974) 1.10
Function of the internal anal sphincter and rectal sensitivity in idiopathic constipation. Digestion (1982) 1.10
Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol (1999) 1.09
Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology (1994) 1.09